Literature DB >> 25034532

Gingerol sensitizes TRAIL-induced apoptotic cell death of glioblastoma cells.

Dae-Hee Lee1, Dong-Wook Kim2, Chang-Hwa Jung3, Yong J Lee4, Daeho Park5.   

Abstract

Glioblastoma multiforme (GBM) is the most lethal and aggressive astrocytoma of primary brain tumors in adults. Although there are many clinical trials to induce the cell death of glioblastoma cells, most glioblastoma cells have been reported to be resistant to TRAIL-induced apoptosis. Here, we showed that gingerol as a major component of ginger can induce TRAIL-mediated apoptosis of glioblastoma. Gingerol increased death receptor (DR) 5 levels in a p53-dependent manner. Furthermore, gingerol decreased the expression level of anti-apoptotic proteins (survivin, c-FLIP, Bcl-2, and XIAP) and increased pro-apoptotic protein, Bax and truncate Bid, by generating reactive oxygen species (ROS). We also found that the sensitizing effects of gingerol in TRAIL-induced cell death were blocked by scavenging ROS or overexpressing anti-apoptotic protein (Bcl-2). Therefore, we showed the functions of gingerol as a sensitizing agent to induce cell death of TRAIL-resistant glioblastoma cells. This study gives rise to the possibility of applying gingerol as an anti-tumor agent that can be used for the purpose of combination treatment with TRAIL in TRAIL-resistant glioblastoma tumor therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Gingerol; Glioblastoma; Reactive oxygen species (ROS); Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL); p53

Mesh:

Substances:

Year:  2014        PMID: 25034532      PMCID: PMC4295120          DOI: 10.1016/j.taap.2014.06.030

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  44 in total

1.  Combination therapy of inhibitors of epidermal growth factor receptor/vascular endothelial growth factor receptor 2 (AEE788) and the mammalian target of rapamycin (RAD001) offers improved glioblastoma tumor growth inhibition.

Authors:  Ranjit K Goudar; Qing Shi; Mark D Hjelmeland; Stephen T Keir; Roger E McLendon; Carol J Wikstrand; Elizabeth D Reese; Charles A Conrad; Peter Traxler; Heidi A Lane; David A Reardon; Webster K Cavenee; Xiao-Fan Wang; Darell D Bigner; Henry S Friedman; Jeremy N Rich
Journal:  Mol Cancer Ther       Date:  2005-01       Impact factor: 6.261

2.  Histologic factors of prognostic significance in the glioblastoma multiforme.

Authors:  P C Burger; R T Vollmer
Journal:  Cancer       Date:  1980-09-01       Impact factor: 6.860

3.  [6]-Gingerol induces caspase 3 dependent apoptosis and autophagy in cancer cells: drug-DNA interaction and expression of certain signal genes in HeLa cells.

Authors:  Debrup Chakraborty; Kausik Bishayee; Samrat Ghosh; Raktim Biswas; Sushil Kumar Mandal; Anisur Rahman Khuda-Bukhsh
Journal:  Eur J Pharmacol       Date:  2012-08-24       Impact factor: 4.432

4.  Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family.

Authors:  R M Pitti; S A Marsters; S Ruppert; C J Donahue; A Moore; A Ashkenazi
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

Review 5.  TRAIL and apoptosis induction by TNF-family death receptors.

Authors:  Shulin Wang; Wafik S El-Deiry
Journal:  Oncogene       Date:  2003-11-24       Impact factor: 9.867

6.  Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model.

Authors:  Ryuta Saito; John R Bringas; Amith Panner; Matyas Tamas; Russell O Pieper; Mitchel S Berger; Krystof S Bankiewicz
Journal:  Cancer Res       Date:  2004-10-01       Impact factor: 12.701

7.  Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

Authors:  Martin J van den Bent; Alba A Brandes; Roy Rampling; Mathilde C M Kouwenhoven; Johan M Kros; Antoine F Carpentier; Paul M Clement; Marc Frenay; Mario Campone; Jean-Francois Baurain; Jean-Paul Armand; Martin J B Taphoorn; Alicia Tosoni; Heidemarie Kletzl; Barbara Klughammer; Denis Lacombe; Thierry Gorlia
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

Review 8.  Bortezomib and TRAIL: a perfect match for apoptotic elimination of tumour cells?

Authors:  L H A M de Wilt; J Kroon; G Jansen; S de Jong; G J Peters; F A E Kruyt
Journal:  Crit Rev Oncol Hematol       Date:  2012-09-01       Impact factor: 6.312

9.  Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Maria Cekanova; Seung Joon Baek
Journal:  Mol Carcinog       Date:  2008-03       Impact factor: 4.784

10.  DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas.

Authors:  Anita C Bellail; Margaret C L Tse; Jin H Song; Surasak Phuphanich; Jeffrey J Olson; Shi Yong Sun; Chunhai Hao
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

View more
  17 in total

1.  A Potential Anti-cancer Compound Separated from the Chloroform Extract of the Chinese Medicine Formula Shenqi San.

Authors:  Lu Shi; Yi-Jun Tu; Si-Qi Ye; Yu Xia; Chao-Zhi Ma; Xiao-Zhi Peng; Yan-Wen Liu; Zhong-Zhu Ai; Peng-Tao You
Journal:  Curr Med Sci       Date:  2020-03-13

2.  RUNX3 enhances TRAIL-induced apoptosis by upregulating DR5 in colorectal cancer.

Authors:  Bo Ram Kim; Seong Hye Park; Yoon A Jeong; Yoo Jin Na; Jung Lim Kim; Min Jee Jo; Soyeon Jeong; Hye Kyeong Yun; Sang Cheul Oh; Dae-Hee Lee
Journal:  Oncogene       Date:  2019-01-28       Impact factor: 9.867

3.  HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells.

Authors:  Dae-Hee Lee; Ki Sa Sung; David L Bartlett; Yong Tae Kwon; Yong J Lee
Journal:  Cell Signal       Date:  2014-11-18       Impact factor: 4.315

4.  Anticancer Effect of Ginger Extract against Pancreatic Cancer Cells Mainly through Reactive Oxygen Species-Mediated Autotic Cell Death.

Authors:  Miho Akimoto; Mari Iizuka; Rie Kanematsu; Masato Yoshida; Keizo Takenaga
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Anti-Cancerous Potential of Polysaccharide Fractions Extracted from Peony Seed Dreg on Various Human Cancer Cell Lines Via Cell Cycle Arrest and Apoptosis.

Authors:  Fang Zhang; Jun-Jun Shi; Kiran Thakur; Fei Hu; Jian-Guo Zhang; Zhao-Jun Wei
Journal:  Front Pharmacol       Date:  2017-03-03       Impact factor: 5.810

Review 6.  Gingers and Their Purified Components as Cancer Chemopreventative Agents.

Authors:  John F Lechner; Gary D Stoner
Journal:  Molecules       Date:  2019-08-07       Impact factor: 4.411

7.  The Inhibitory Effect of 6-Gingerol on Ubiquitin-Specific Peptidase 14 Enhances Autophagy-Dependent Ferroptosis and Anti-Tumor in vivo and in vitro.

Authors:  Yun Tsai; Changbo Xia; Zhongwen Sun
Journal:  Front Pharmacol       Date:  2020-11-13       Impact factor: 5.810

8.  Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.

Authors:  Yingmei Zhao; Binqiang Tian; Yong Wang; Haiying Ding
Journal:  Med Sci Monit       Date:  2017-10-26

9.  The Influence of Lycopene, [6]-Gingerol, and Silymarin on the Apoptosis on U-118MG Glioblastoma Cells In Vitro Model.

Authors:  Justyna Czarnik-Kwaśniak; Konrad Kwaśniak; Paulina Kwasek; Elżbieta Świerzowska; Agata Strojewska; Jacek Tabarkiewicz
Journal:  Nutrients       Date:  2019-12-30       Impact factor: 5.717

10.  Carbon nanotubes supported tyrosinase in the synthesis of lipophilic hydroxytyrosol and dihydrocaffeoyl catechols with antiviral activity against DNA and RNA viruses.

Authors:  Giorgia Botta; Bruno Mattia Bizzarri; Adriana Garozzo; Rossella Timpanaro; Benedetta Bisignano; Donatella Amatore; Anna Teresa Palamara; Lucia Nencioni; Raffaele Saladino
Journal:  Bioorg Med Chem       Date:  2015-07-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.